Bill Gates has long been a proponent of vaccines in general and more recently, mRNA vaccine technology.
Now, he may have his sights set on developing a vaccine to combat climate change by targeting the methane emissions of livestock.
ArkeaBio, a Boston-based ag-biotech startup, recently raised $26.5 million in a Series A financing round to “reduce greenhouse gas emissions” via the development of a “methane vaccine,” the company announced in a May 8 press release.
Breakthrough Energy Ventures, founded by Gates and which first invested in ArkeaBio in 2022, led the financing round.
The company said:
“ArkeaBio’s vaccine will provide an innovative, cost-effective, and scalable solution to reduce the world’s livestock methane emissions, which currently generate the equivalent of 3 Billion Tonnes of CO2 annually and represent 6% of annual Greenhouse gas emissions.”
Hellbound and Down 